Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers

Neurology

Volumn 80, Issue 9, 2013, Pages 792-799

  Okai, David ^a   Askey Jones, Sally ^a   Samuel, Michael ^b   O'sullivan, Sean S ^c   Chaudhuri, K Ray ^b   Martin, Anne ^e   Mack, R Joel ^d   Brown, Richard G ^a   David, Anthony S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e Oregon Health and Science University ^*

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; ANXIETY; ARTICLE; CAREGIVER; CAREGIVER BURDEN; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; FEASIBILITY STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; IMPULSE CONTROL DISORDER; MALE; MEDICAL CARE; MINI MENTAL STATE EXAMINATION; MORBIDITY; NEUROPSYCHIATRY; NURSING CARE; OUTCOME ASSESSMENT; PARKINSON DISEASE; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL ADAPTATION; STANDARD; AGED; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; IMPULSIVENESS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; TREATMENT OUTCOME;

AGED; CAREGIVERS; COGNITIVE THERAPY; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; PARKINSON DISEASE; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84875185656     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182840678     Document Type: Article

References (33)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000.
2. Giovannoni G, O'Sullivan JD, Turner K, Manson AJ, Lees AJL. Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies. J Neurol Neurosurg Psychiatry 2000;68:423-428.
3. Lim S-Y, Evans AH, Miyasaki JM. Impulse control and related disorders in Parkinson's disease. Ann NY Acad Sci 2008;1142:85-107.
4. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
5. Leroi I, Harbishettar V, Andrews M, et al. Carer burden in apathy and impulse control disorders in Parkinson's disease. Int J Ger Psychiatry 2012;27:160-166.
6. Voon V, Sohr M, Lang AE, et al. Impulse control disorders in Parkinson disease: a multicenter case-control study. Ann Neurol 2011;69:986-996.
7. Delaney M, Leroi I, Simpson J, Overton PG. Impulse control disorders in Parkinson's disease: a psychosocial perspective. J Clin Psychol Med Settings 2012;19:338- 346.
8. Okai D, Samuel M, Askey-Jones S, David AS, Brown RG. Impulse control disorders and dopamine dysregulation in Parkinson's disease: a broader conceptual framework. Eur J Neurol 2011;18:1379-1383.
9. Rabinak CA, Nirenberg MJ. Dopamine agonist withdrawal syndrome in Parkinson disease. Arch Neurol 2010;67: 58-63.
10. Shotbolt P, Moriarty J, Costello A, et al. Relationships between deep brain stimulation and impulse control disorders in Parkinson's disease, with a literature review. Parkinsonism Relat Disord 2012;18:10-16.
11. Lim S-Y, O'Sullivan SS, Kotschet K, et al. Dopamine dysregulation syndrome, impulse control disorders and punding after deep brain stimulation surgery for Parkinson's disease. J Clin Neurosci 2009;16:1148-1152.
12. Sylvain C, Ladouceur R, Boisvert JM. Cognitive and behavioural treatment of pathological gambling: a controlled study. J Consult Clin Psychol 1997;65:727-732.
13. Milton S, Crino R, Hunt C, Prosser E. The effect of compliance-improving interventions on the cognitive-behavioural treatment of pathological gambling. J Gambl Stud 2002;18:207-229.
14. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001; 57:S34-S38.
15. Weintraub D, Hoops S, Shea JA, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Mov Disord 2009;24:1461-1467.
16. Evans AH, Katzenschlager R, Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004;19:397-405.
17. Voon V, Fox SH. Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch Neurol 2007;64:1089-1096.
18. Lawrence AD, Evans AH, Lees AJ. Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? Lancet Neurol 2003;2:595-604.
19. Molloy D, Alemayehu E, Roberts R. Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. Alzheimers Dis Assoc Disord 1991;5:206-207.
20. National Institute of Mental Health. Clinical Global Impressions. In: Guy W, ed. ECDEU Assessment Manual for Psychopharmacology, rev ed. Rockville: NIMH; 1970.
21. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308.
22. Mundt JC, Marks IM, Shear MK, Greist JM. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002;180:461-464.
23. Goldberg DP, Hillier V. A scaled version of the General Health Questionnaire. Psychol Med 1979;9:139-145.
24. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psych Corp; 1996.
25. Beck A, Steer R. Manual for the Beck Anxiety Inventory. San Antonio: Psych Corp; 1990.
26. Rust J, Bennun I, Crowe M, Golombok S. The Golombok Rust inventory of marital state (GRIMS). Sex Marital Ther 1986;1:55-60.
27. Fahn S, Elton R, Committee UD, eds. Unified Parkinson's Disease Rating Scale. Florham Park, NJ: Macmillan Healthcare Information; 1987.
28. Tomlinson CL, Stowe R, Patel S, et al. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
29. Zarit SH, Todd PA, Zarit JM. Subjective burden of husbands and wives as caregivers: a longitudinal study. Gerontologist 1986;26:260-266.
30. Secker DL, Brown RG. Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: a preliminary randomised controlled trial. J Neurol Neurosurg Psychiatry 2005;76:491-497.
31. Cohen J. A power primer. Psychol Bull 1992;112:155.
32. Thomas A, Bonanni L, Gambi F, Di Iorio A, Onofrj M. Pathological gambling in Parkinson disease is reduced by amantadine. Ann Neurol 2010;68:400-404.
33. Weintraub D, Sohr M, Potenza MN, et al. Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study. Ann Neurol 2010;68:963-968.